Pionyr Immunotherapeutics

Pionyr Immunotherapeutics

  • Founded: 2015
  • Location: South SF, CA
  • Employee range: 50 - 200
  • Clinical stage: Clin1
  • Therapy area: Solid tumors
  • Drug types: ONC
  • Lead product: PY314
  • Product link: https://www.pionyrtx.com/pipeline/
  • Funding: $275M 49.9% equity Gilead Jun 2020; $62M B Dec 2017; $8M A Jan 2017



job board

Short description:

Immuno-Oncology, Monoclonal Antibody

Drug notes:

PY159 Clin1 solid tumors; PY265 Clin0 solid tumors; undisclosed RD undisclosed

Long description:

Contact us to add description: recruit@workinbiotech.com


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com